Calcium: Clinical Trials

32 trials of Calcium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 6 unknown, 2 active not recruiting, 1 not yet recruiting. 32 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 432Completed 21, Unknown 6, Active not recruiting 2, Not yet recruiting 1, Recruiting 1, Withdrawn 1

Follow Calcium: new trials by email Literature Review of Calcium trials Research Report on Calcium

Trials (filtered) newest first · largest first

All 32 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD
Romosozumab, Zoledronic Acid 5 MG in 5 ML Injection, Calcium 500 mg and Vitamin D3 800 IU - Osteoporosis in Post-menopausal Women
Phase 4Not yet recruitingSahlgrenska University Hospital2162027-01-112026-08-19
Efficacy and Safety of Low-dose Calcium Supplementation in Pregnancy
Calcium - Pregnancy
Phase 4CompletedFirst People's Hospital of Hangzhou1172025-09-102026-08-25
Low Sodium Oxybate in Patients With Idiopathic Hypersomnia
Low Sodium Oxybate, 24-hour polysomnography, Nextsense EEG earbuds - Idiopathic Hypersomnia
Phase 4RecruitingMayo Clinic302024-02-142026-05-12
Efficacy and Safety of Combination Denosumab With Eldecalcitol for Postmenopausal Women With Osteoporosis.(ESCORT)
Eldecalcitol, Native Vitamin D, Denosumab - Osteoporosis in Postmenopausal Women
Phase 4CompletedXi'an Honghui Hospital1002023-08-242025-11-24
Role of IV Calcium to Prevent Diltiazem-related Hypotension
Sodium chloride, 90 mg of calcium, 180 mg Calcium - Atrial Fibrillation, Rapid Ventricular Response
Phase 4CompletedHaseki Training and Research Hospital2172023-01-012024-07-11
PRevEnting FracturEs in REnal Disease - 1
Denosumab 60 mg/ml, Calcium and vitamin D prophylaxis, Monitoring of post-injection calcium and phosphate - Kidney Diseases, Dialysis; Complications
Phase 4Active not recruitingWestern University, Canada602022-06-112025-05-31
Effects of Denosumab on Bone Fusion in Osteoporotic Patients After Lumbar Fusion
Denosumab 60 mg/ml Injectable Solution [Prolia], calcium and vitamin D - Osteoporosis, Fusion of Spine, Lumbar Region
Phase 4UnknownShanghai Changzheng Hospital1162021-10-092022-01-24
Romosozumab Use to Build Skeletal Integrity
Romosozumab, Placebo, Zoledronic acid - Osteoporosis, Osteoporosis, Postmenopausal
Phase 4Active not recruitingSusan L. Greenspan1842021-09-152026-02-17
Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic Women
Generic Zoledronic Acid, Original Zoledronic Acid, calcium - Osteoporosis, Postmenopausal
Phase 4UnknownCttq4662017-06-012017-05-23
Preventing Osteoporosis Using Denosumab
denosumab, Placebo, Calcium and Vitamin D - Osteoporosis, Postmenopausal, Osteoporosis
Phase 4CompletedSusan L. Greenspan2012016-06-012024-09-19
Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)
Zoledronic acid, vitamin D, calcium - Osteoporotic Fractures, Osteoporosis, Postmenopausal
Phase 4CompletedSusan L. Greenspan3102016-01-012023-09-26
Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis
Vitamin D, Calcium, Placebo Vit D - Type 2 Diabetes Mellitus, Pulmonary Tuberculosis
Phase 4UnknownDow University of Health Sciences4352014-12-012014-06-23
Low Dose Calcium to Prevent Preeclampsia
calcium, Educational sessions - Pre-Eclampsia, Hypertension, Pregnancy-Induced
Phase 4CompletedFederal University of São Paulo10402014-10-012023-10-12
Efficacy of Vitamin D and Calcium Supplementation on the Prevention of Recurrences in BPPV
400IU cholecalciferol and 500mg of elemental calcium as calcium carbonate - Benign Paroxysmal Positional Vertigo
Phase 4CompletedSeoul National University Bundang Hospital10502013-12-012017-11-17
The Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels
Calcitriol, Alfacalcidol, Cholecalciferol - Osteoporosis
Phase 4UnknownSeoul National University Hospital882013-01-012013-01-10
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide, Risedronate, Placebo - Postmenopausal Osteoporosis
Phase 4CompletedEli Lilly and Company13662012-10-012019-09-23
Anti-proteinuric Effect of Calcitriol in Non-diabetic Kidney Disease Patients
Calcitriol, Placebo - Proteinuria
Phase 4UnknownSeoul National University Hospital2402012-01-012012-04-10
The Effect of Vitamin D Supplementation in Type 2 Diabetes
Vitamin D3, placebo - DIABETES MELLITUS
Phase 4CompletedChuncheon Sacred Heart Hospital1582011-12-012013-05-15
A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)
alendronate 70-mg/vitamin D3 5600 IU combination tablet (Fosamax Plus), Calcitriol, Calcium 500 mg - Osteoporosis, Postmenopausal
Phase 4CompletedOrganon and Co2192011-06-192024-06-20
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Teriparatide, Risedronate, Placebo - Osteoporosis
Phase 4CompletedEli Lilly and Company2242009-04-012019-09-25

Showing 20 of 32. Sign in to see all of them.

Conditions studied

Osteoporosis (11)  ·  Osteoporosis, Postmenopausal (7)  ·  Bone Diseases, Metabolic (6)  ·  Fractures, Bone (3)  ·  Osteoporotic Fractures (3)  ·  Diabetes Mellitus (2)  ·  Vitamin D Deficiency (2)  ·  Atrial Fibrillation (1)  ·  Benign Paroxysmal Positional Vertigo (1)  ·  Chronic Kidney Disease-Mineral and Bone Disorder (1)  ·  Colles' Fracture (1)  ·  Crohn Disease (1)  ·  Depression (1)  ·  Depression, Postpartum (1)  ·  Diabetes Mellitus, Type 2 (1)

Sponsors

Eli Lilly and Company (3)  ·  Susan L. Greenspan (3)  ·  Mayo Clinic (2)  ·  Seoul National University Hospital (2)  ·  Aristotle University Of Thessaloniki (1)  ·  Boston VA Research Institute, Inc. (1)  ·  Charite University, Berlin, Germany (1)  ·  Chuncheon Sacred Heart Hospital (1)  ·  Cttq (1)  ·  Donaghue Medical Research Foundation (1)  ·  Dow University of Health Sciences (1)  ·  Federal University of São Paulo (1)  ·  First People's Hospital of Hangzhou (1)  ·  Haseki Training and Research Hospital (1)  ·  Imperial College London (1)

Countries

United States (11)  ·  Brazil (4)  ·  South Korea (4)  ·  Canada (3)  ·  China (3)  ·  Germany (3)  ·  Greece (3)  ·  Spain (3)  ·  Czechia (2)  ·  France (2)  ·  Italy (2)  ·  Mexico (2)  ·  Puerto Rico (2)  ·  Argentina (1)  ·  Austria (1)

Top investigators

Susan L Greenspan, MD (3)  ·  Adem Az, M.D. (1)  ·  Ailsa L Hart, BA(Hons), BM BCh, MRCP, PhD (1)  ·  Anastasios N. Lasaridis, MD, PhD (1)  ·  Andrew N Milestone, BSc(Hons) MBBS MRCP (1)  ·  Anne Kenny, MD (1)  ·  Antonio A Lazzari, MD (1)  ·  Chad Ruoff, MD (1)  ·  Chan Soo Shin, MD, PhD (1)  ·  Changgui Shi, M.D. (1)  ·  Daniel C. Hatton, PhD (1)  ·  Dieter Felsenberg, Prof. Dr. (1)

Results publications

PMID 15093843, PMID 1539892, PMID 17431740, PMID 24748637, PMID 25929192, PMID 29129436, PMID 29329484, PMID 30659410, PMID 30883492, PMID 32157334, PMID 32474650, PMID 33305842, PMID 36442264, PMID 39223504, PMID 39577214, PMID 40935429, PMID 42513484, PMID 7056937

NIH funding

R01AG050302 (1), R01AG052123 (1), R01AG066825 (1), R21MH063242 (1)